Details for New Drug Application (NDA): 021502
✉ Email this page to a colleague
The generic ingredient in ANTHELIOS SX is avobenzone; ecamsule; octocrylene. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the avobenzone; ecamsule; octocrylene profile page.
Summary for 021502
Tradename: | ANTHELIOS SX |
Applicant: | Loreal Usa |
Ingredient: | avobenzone; ecamsule; octocrylene |
Patents: | 0 |
Suppliers and Packaging for NDA: 021502
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502 | NDA | L'Oreal USA Products Inc | 49967-017 | 49967-017-01 | 1 TUBE in 1 CARTON (49967-017-01) / 100 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CREAM;TOPICAL | Strength | 2%;2%;10% | ||||
Approval Date: | Jul 21, 2006 | TE: | RLD: | Yes |
Expired US Patents for NDA 021502
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Loreal Usa | ANTHELIOS SX | avobenzone; ecamsule; octocrylene | CREAM;TOPICAL | 021502-001 | Jul 21, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription